Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

Recap: Haemonetics Q3 Earnings

 

Haemonetics (NYSE:HAE) reported its Q3 earnings results on Tuesday, February 8, 2022 at 06:00 AM.

Here's what investors need to know about the announcement.

Also check this: PayPal And 3 Other Stocks Bought By Insiders

Earnings

Haemonetics beat estimated earnings by 15.07%, reporting an EPS of $0.84 versus an estimate of $0.73.

Revenue was up $19.40 million from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.01, which was followed by a 2.18% increase in the share price the next day.

Here's a look at Haemonetics's past performance:

 

Quarter Q2 2022 Q1 2022 Q4 2021 Q3 2021
EPS Estimate 0.61 0.46 0.67 0.65
EPS Actual 0.60 0.50 0.46 0.81
Revenue Estimate 241.40M 219.35M 222.98M 224.29M
Revenue Actual 239.90M 228.53M 225.03M 240.37M

To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.